/lifesciences?utm_source=rss&utm_medium=rss&utm_campaign=section Latest articles for: Life Sciences Copyright 2025 ¼«ËÙÈü³µ. en-US Wed, 30 Apr 2025 18:08:43 +0000 /lifesciences/articles/2332011?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2332011 A biotechnology company accusing the National Football League's largest alumni club of breaking a contract in retaliation for being questioned about its use of government funds told a Georgia federal court Tuesday the company would add details to its suit to head off the club's bid to have the suit thrown out. Wed, 30 Apr 2025 18:08:33 +0000 /lifesciences/articles/2332077?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2332077 The Patent Trial and Appeal Board has found claims in a patent owned by AbbVie's Pharmacyclics unit related to its cancer drug Imbruvica were invalid, the latest in a larger intellectual property fight with BeiGene. Wed, 30 Apr 2025 17:53:31 +0000 /lifesciences/articles/2332432?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2332432 Enforcers opened high stakes court proceedings against Meta Platforms and Google for monopolization claims that could force the tech giants to sell pieces of the companies, while also moving ahead with several challenges and reviews of pending deals in other industries. Here, ¼«ËÙÈü³µ looks at the major merger review developments from April. Wed, 30 Apr 2025 17:30:25 +0000 /lifesciences/articles/2332356?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2332356 Michigan Attorney General Dana Nessel took aim at pharmacy benefit managers Express Scripts and Prime Therapeutics this week in a lawsuit accusing them of a price-fixing deal the state said has crippled pharmacies. Wed, 30 Apr 2025 17:08:25 +0000 /lifesciences/articles/2332507?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2332507 Honeywell has dropped its lawsuit accusing a sourcing company of making up quality concerns to bail on a contract for medical-grade gloves, according to a notice filed in the North Carolina Business Court. Wed, 30 Apr 2025 16:43:30 +0000 /lifesciences/articles/2332542?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2332542 Buchanan Ingersoll & Rooney PC has added a second Frier Levitt attorney with experience representing pharmacies to its new pharmacy benefit manager contract and audit defense team in Newark, New Jersey, the firm announced Wednesday. Wed, 30 Apr 2025 15:12:21 +0000 /lifesciences/articles/2330100?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2330100 Quantum computing is projected to pose significant updates to current practices in cryptography, making the issue relevant to policymakers and the legal profession generally, particularly when it comes to data storage, privacy regulations and pharmaceutical industry market changes, say professors at the University of San Francisco. Wed, 30 Apr 2025 13:19:24 +0000 /lifesciences/articles/2332033?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2332033 A California federal judge has dismissed a proposed class action alleging Thang Botanicals and FTLS Holdings LLC mislead consumers about addictive qualities of their kratom products after the plaintiffs failed to file an amended complaint on time. Wed, 30 Apr 2025 12:49:18 +0000 /lifesciences/articles/2329525?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2329525 Practitioners leaving a longtime government role for private practice — as when I departed the U.S. Department of Justice’s environmental enforcement division — should prioritize finding a firm that shares their principles, values their experience and will invest in their transition, says John Cruden at Beveridge & Diamond. Wed, 30 Apr 2025 10:11:55 +0000 /lifesciences/articles/2332275?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2332275 Novartis AG said Wednesday it has agreed to acquire Latham & Watkins LLP-advised Regulus Therapeutics Inc. for up to $1.7 billion in a deal that strengthens the Swiss pharmaceutical giant's kidney disease portfolio with a promising RNA-based therapy. Tue, 29 Apr 2025 23:36:57 +0000 /lifesciences/articles/2331999?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2331999 Gilead agreed to pay $202 million to the federal government and some states to resolve claims it made improper payments to high-volume prescribers of its HIV drugs, New York federal prosecutors announced Tuesday. Tue, 29 Apr 2025 23:32:49 +0000 /lifesciences/articles/2332089?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2332089 A New York federal jury on Tuesday returned a verdict finding that CVS Health Corp. subsidiary Omnicare illegally billed the federal government to the tune of $135.6 million, one of the largest jury verdicts in a False Claims Act case, according to a statement from the U.S. Department of Justice. Tue, 29 Apr 2025 21:43:26 +0000 /lifesciences/articles/2332003?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2332003 The U.S. Supreme Court's latest attempt to address a pressing question about class certification standards may be doomed by a procedural hiccup, with a majority of justices expressing concern Tuesday that they didn't have the authority to wade into a dispute over approval of a class that contains uninjured members. Tue, 29 Apr 2025 21:34:12 +0000 /lifesciences/articles/2331692?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2331692 The D.C. federal judge tasked with deciding dueling summary judgments in litigation accusing the government of blocking drugmakers' efforts to reshape the way they do rebates seemed skeptical of endorsing a vision of the program that could have "potentially devastating consequences." Tue, 29 Apr 2025 19:20:32 +0000 /lifesciences/articles/2331828?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2331828 A Missouri bankruptcy judge on Tuesday signed off on a consumer privacy watchdog for 23andMe's Chapter 11 after the genetic testing group and 30 states agreed that a statutorily authorized ombudsman would be the best way to vet a Chapter 11 sale that includes 15 million users' DNA information. Tue, 29 Apr 2025 18:08:03 +0000 /lifesciences/articles/2331834?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2331834 Xencor has urged the full Federal Circuit to review a decision rejecting its application for an antibody patent that used the so-called Jepson claim format, saying the case set an "onerous requirement" that is nearly impossible to meet and "eliminates any incentive" to use the format. Tue, 29 Apr 2025 17:47:33 +0000 /lifesciences/articles/2331761?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2331761 The Federal Circuit on Tuesday adopted a test for determining if trademarks are generic when considering claims on distinctive colors, affirming a trademark board precedent used to reject an Indonesian medical supply company's efforts to claim a trademark for dark green surgical gloves. Tue, 29 Apr 2025 17:46:32 +0000 /lifesciences/articles/2331793?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2331793 A Texas federal judge has allowed drugmaker GenBioPro to join a legal fight over access to the abortion drug mifepristone, finding that the company has a distinct interest in defending federal approval of the generic version of the medication. Tue, 29 Apr 2025 16:57:29 +0000 /lifesciences/articles/2331736?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2331736 The Office of the U.S. Trade Representative on Tuesday issued its annual global intellectual property report that has placed close trading partner Mexico on its list of countries to keep the closest eye on. Tue, 29 Apr 2025 15:46:10 +0000 /lifesciences/articles/2331466?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2331466 Latham & Watkins LLP has welcomed back an intellectual property attorney who spent the past nine years at Cooley LLP to bolster its healthcare and life sciences practice, including advising clients about licensing and transactional matters.